Effectiveness and implementation of evriMED for adherence to treatment among TB patients in Kilimanjaro, Tanzania

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201811755733759

Enrollment

660

Registered

2018-11-08

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

EVRIMED

STANDARD CARE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Diagnosed drug-susceptible TB patients (smear positive and symptom based) • Attending care at any of the TB treatment centers in Kilimanjaro region • Age between 18 and 65 • Living in Kilimanjaro Region • Willing to use the evriMED-device • Willing to come to the clinic according to standard care • Able to read and understand SMS • Able to understand and willing to sign the informed consent document

Exclusion criteria

Exclusion criteria: • Participating in other trials • Previously

Design outcomes

Primary

Measure	Time frame
Adherence to treatment	—

Secondary

Measure	Time frame
STIGMATIZATION	—

Countries

Tanzania

Contacts

Public ContactPRISCA NJAU

ADMINISTRATOR

P.NJAU@KCRI.AC.TZ+255272754201

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026